In this study, we demonstrated the cardioprotective effect of paroxetine, a GRK2 inhibitor, in an animal model of CH, particularly focusing on its inhibitory effect on GRK2-IκBα modulation of NF-κB-mediated prohypertrophic and profibrotic gene expression. Here, NFKB1 is linked to cyclic hematopoiesis.